Improved Patient Outcomes
MedXPrime™ Pharmacogenetic Testing
The New Frontier of Medicine Begins Here. . . .
We are on the cusp of a fascinating new era of healthcare, literally a new frontier in the world of medicine.
The era of ‘Personalized Medicine’ has now arrived.
Genetic variability has long been accepted and promoted within both the scientific community and the healthcare industry. Advances in molecular testing, and completion of the mapping of the human genome in particular, give credence to the fact that patients respond differently to medications based on their individual genetic makeup. Such advancements brought about the concept of personalized medicine, the practice of using an individual’s genetic profile to guide decisions for the prevention, treatment and diagnosis of disease. Correspondingly, a major problem in the healthcare industry is the variability of drug efficacy from patient to patient. While some patients complain about lack of effectiveness, other patients suffer from adverse drug reactions (ADRs). Personalized medicine has the ability to alleviate the burden of individual genetic variability and the resulting varied drug response across different patient populations.
The MedXPrime Mission is to reach
Unprecedented Support System
- Toll-free Courtesy Consultation line for health care providers with a pharmacogenomic trained expert
- Initial inservice medical staff orientation and training.
- No cost for PGx collection supplies or mailing.
- Online portal for quick access to PGx reports.
What People are Saying:
“Pharmacogenomics holds great promise to shed scientific light on the often risky and costly process of drug development, and to provide greater confidence about the risks and benefits of drugs in specific populations. Pharmacogenomics is a new field, but we intend to do all we can to use it to promote the development of medicines. By providing practical guidance on how to turn the explosion of pharmacogenomic information into real evidence on new drugs, we are taking an important step toward that goal.”
—Mark B. McClellan, M.D., Ph.D., FDA, Commissioner. On the issuance of “Draft Guidance for Industry: Pharmacogenomic Data Submissions.”
“Without (Pharmacogenetics) testing, neither you nor your doctor knows exactly how you’ll react to the medication. It may not work for you, or you may have serious side effects such as bleeding. You might have to try different doses — or even different medications — before finding a treatment that works for you. Pharmacogenomics speeds up that process. Before you take a single dose of medication, you can have a test to see how you’re likely to respond to the medication.”
—Mayo Clinic,On Pharmacogenetics
“The current gap between current practice and that which will soon be enabled by new personalized medicine technologies could arguably mean the difference between life and death for thousands of patients per year. Physicians are likely to be hauled into court and called to account for this discrepancy unless steps are taken to provide physicians with better education and guidelines to integrate the new data and technologies into their clinical practice. The window of opportunity to act is short. Once the litigation snowball starts to roll, it will quickly become unstoppable.”
—Gary E Marchant, Doug E Campos-Outcalt, Rachel A Lindor,Personalized Medicine. 2011;8(4):457-467.